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Background: Use of the femoral vein for the injection of illicit drugs (i.e. groin injecting) has been linked to various
health-related harms, including deep vein thrombosis. However, little is known about the prevalence of groin
injecting and factors that predict this practice among people who inject drugs (PWID) in Thailand. We sought to
investigate the prevalence and factors associated with groin injecting in Bangkok, Thailand.
Methods: Data were derived from the Mitsampan Community Research Project in Bangkok between July and
October 2011. Multivariate logistic regression was used to identify factors associated with groin injecting in the last
six months.
Results: Among 437 participants, 34.3% reported groin injecting in the last six months. In multivariate analyses,
factors positively associated with groin injecting included: having higher than secondary education (adjusted odds ratio
[AOR] = 1.59; 95% confidence interval [CI]: 1.00 – 2.56), weekly midazolam injection (AOR = 8.26; 95% CI: 5.04 – 14.06), and
reports of having had drugs planted on oneself by police (AOR = 2.14; 95% CI: 1.37 – 3.36).
Conclusions: Over one-third of our sample of Thai PWID reported recent groin injecting. Frequent midazolam injection
and higher education were found to be associated with groin injecting. That high intensity PWID were more likely to
inject in the groin is concerning given the known negative consequences associated with the groin as a site of injection.
Additionally, PWID who reported drug planting by police were more likely to inject in the groin, suggesting that reliance
on law enforcement approaches may undermine safe injection practices in this setting. These findings highlight the need
for evidence-based interventions to address the harms associated with groin injecting, including efforts to alert PWID to
risks of groin injecting, the distribution of appropriate injecting equipment, and efforts to encourage use of other injecting
sites.
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In recent years, there has been growing concern over the
use of the femoral vein for intravenous access (i.e. groin
injecting) by people who inject drugs (PWID). While the
groin is rarely the initial site of injection for PWID, there
is often a progression towards groin injecting after years
of continued injecting [1]. The most probable reason for
this progression may be related to the physical health
complications associated with repeated injecting in other* Correspondence: uhri-tk@cfenet.ubc.ca
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stated.sites, including the loss or perceived loss of peripheral vein
access [1,2].
Historically, groin injection has been described as an ex-
tremely high-risk behaviour and a “last resort” for many
PWID [3]; yet more recently, the use of the femoral vein
as a site of injection has become increasingly normalized
among PWID populations [4]. Previous research have
identified reasons for the increasing use of groin injecting,
which include: the groin being a reliable site of injection,
and that it allows for a convenient and speedy injection es-
pecially among PWID who inject in public [4,5]. Further-
more, the groin appears to be a discreet site of injection,
and allows track marks to remain hidden from the public
and police [4,6].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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among PWID [7,8]. Midazolam is a fast, short-acting
benzodiazepine that has potent amnesic and sedative
properties [9]. The increasing use of midazolam is believed
to be a consequence of the Thai government’s reliance on
heavy drug law enforcement [7], which has indirectly
affected the availability and pricing of heroin and other
illegal drugs [10,11]. The low price of midazolam, and the
fact that midazolam is easy to acquire as a licit drug,
makes this substance an appealing alternative to heroin
for Thai PWID [8]. The use of this particular drug may be
a concern given that there may be health-related compli-
cations (e.g., venous blockage leading to amputation) that
could adversely impact the health of PWID [12].
The normalization, and subsequently, the apparent in-
creasing use of groin injection by PWID represents a ser-
ious public health issue. Research suggests that groin
injecting is associated with a wide array of health prob-
lems, including deep vein thrombosis [13,14], leg ulcers
[15], venous gangrene [16] and injection-related infections
[17]. In addition, its close proximity to the femoral nerve
increases the risk of nerve damage and related complica-
tions [2,16]. Despite the above issues, the practice of groin
injecting has not, to our knowledge, been extensively doc-
umented among PWID in Asia, a setting where evidence
of police corruption and violence have been observed [11].
For instance, studies have indicated that police in Thailand
have been guilty of planting drugs on suspected PWID to
extort money or provide grounds for arrest [18]. We
sought to identify the prevalence and factors associated
with groin injecting among a community-recruited sample
of PWID in Bangkok, Thailand.
Methods
The Mitsampan Community Research Project is a col-
laborative research project involving the Mitsampan
Harm Reduction Center (Bangkok, Thailand), the Thai
AIDS Treatment Action Group (Bangkok, Thailand),
Chulalongkorn University (Bangkok, Thailand), and the
British Columbia Centre for Excellence in HIV/AIDS
(Vancouver, Canada). During July and October of 2011,
the research partners undertook a cross-sectional study
involving 440 community-recruited PWID who were re-
cruited through peer-based outreach efforts and word-
of-mouth. Individuals residing in Bangkok or adjacent
provinces who had injected drug(s) in the past six
months were eligible for participation in the study. All
participants provided oral informed consent and com-
pleted an interviewer-administered questionnaire eliciting
information about demographic characteristics, drug use,
HIV risk behaviour, and criminal justice system exposure.
The survey instrument was developed in consultation with
peer researchers, which involved brainstorming key issues
in the community and designing a questionnaire to reflectthe community’s concerns. Prior to finalizing the sur-
vey instrument, follow-up discussions, piloting, and
fine-tuning were conducted to ensure the accuracy and
feasibility of the instrument. Additionally, language dis-
crepancies between English and Thai versions were ad-
justed with the assistance of bilingual co-authors (KK,
PS) of the manuscript. While this survey instrument
has yet to be officially validated, our findings using the
same questionnaire have been consistent with prior re-
search conducted in Bangkok [19,20]. Upon completion
of the questionnaire, participants were provided with a
stipend of 350 Thai Baht (approximately $11 USD).
The study has been approved by the research ethics
boards at Chulalongkorn University and University of
British Columbia.
For the present analysis, the outcome of interest was
groin injection in the past six months. We compared
PWID who had and had not injected in the groin using bi-
variate statistics and multivariate logistic regression. All par-
ticipants who completed the survey between July and
October 2011 were eligible for inclusion. Variables consid-
ered included: median age (≥ 38 years vs. < 38 years), gen-
der (male vs. female), higher than secondary level education
(≥ secondary education vs. < secondary education), heroin
injection (> weekly vs. ≤ weekly vs. none), midazolam injec-
tion (> weekly vs. ≤ weekly vs. none), methamphetamine in-
jection (> weekly vs. ≤ weekly vs. none), length of injecting
career (years), binge drug use (yes vs. no), syringe sharing
(yes vs. no), injecting in public places (yes vs. no), having
had a non-fatal overdose (yes vs. no), reporting needing
help injecting (yes vs. no), injected with others on a fre-
quent basis (> 75% of the time vs. ≤ 75% of the time),
ever experienced barriers accessing healthcare services (any
vs. none), and reported a history of drug planting by police
(i.e., having drugs planted on oneself by police) (yes vs. no).
All variables refer to the previous six months unless other-
wise indicated. All variables refer to the previous six
months unless otherwise indicated. Binge drug use refers to
having injected drugs more than usual. PWID who injected
in public places were coded as “yes” if they injected drug(s)
in the following places: public washroom, under highways,
in bush/jungle, parking lot, abandoned building, bus, phone
booth, shopping mall, and temple. Barriers to accessing
healthcare were defined as in a previous study [21], and in-
cluded barriers such as: long wait lists/times, stigma and
discrimination by healthcare professionals, among others.
‘Drug planting by police’ was included as a potential ex-
planatory variable given that anecdotal evidence from a
study in Mexico, a setting with a similar law enforcement
approach to drug control as Thailand, suggested an associ-
ation between a history of negative experiences with law
enforcement and groin injecting [6].
To examine bivariate associations between each inde-
pendent categorical variable and groin injecting, we used
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one or more of the cells contained values less than or
equal to five. For continuous variables, we used simple
logistic regression. We applied an a priori-defined statis-
tical protocol based on examination of the Akaike Infor-
mation Criterion (AIC) and p-values to construct an
explanatory multivariate logistic regression model. First,
we constructed a full model including all variables ana-
lyzed in bivariate analyses. After noting the AIC of the
model, we removed the variable with the largest p-value
and built a reduced model. We continued this iterative
process until no variables remained for inclusion. We se-
lected the multivariate model with the lowest AIC score.
Given previous work suggesting a strong association be-
tween drug planting by police and midazolam injecting
[18], as a subanalysis, we examined potential interaction
effects between drug planting by police and midazolam in-
jection in the previous six months. We also ran a second
multivariate logistic regression model that included a his-
tory of midazolam injection (yes vs. no) in replacement of
the variable ‘weekly midazolam injection in the previous
six months’ on the basis that past injection of midazolam
could predict future groin injection. All p-values were two
sided.
Results
In total, 437 individuals completed the survey and partici-
pated in this study. Three participants were excluded from
the original sample given that data for these individuals
were incomplete. The sample included 86 (19.7%) females.
The median age of participants was 38 years (interquartile
range: 34 – 48 years). Among our study sample, 34.3% re-
ported having injected in the groin in the past six months.
As indicated in Table 1, in bivariate analyses, factors sig-
nificantly and positively associated with groin injecting in-
cluded: higher than secondary level education (odds ratio
[OR] = 1.83; 95% confidence interval [CI]: 1.20 – 2.78), >
weekly heroin injection vs. none (OR = 1.83; 95%CI: 1.09 –
3.08), > weekly midazolam injection vs. none (OR = 10.93;
95%CI: 5.59 – 21.37), binge drug use (OR = 1.90; 95%CI:
1.25 – 2.90), and reporting having drugs planted by police
(OR = 2.14; 95%CI: 1.43 – 3.20). Less than weekly metham-
phetamine injection was negatively associated with the out-
come in bivariate analysis (OR = 0.60; 95%CI: 0.37 – 0.98).
The adjusted estimates of factors associated with groin
injection are presented in Table 2. In Model 1, factors
that remained positively and independently associated
with groin injecting were weekly midazolam injection
(adjusted odds ratio [AOR] = 9.67; 95% CI: 5.10 – 20.06)
and having drugs planted by police (AOR = 2.09; 95% CI:
1.33 – 3.29). An analysis of potential interaction effects
involving drug planting by police and a history of mid-
azolam injection was conducted but failed to yield any
statistically significant effects. Alternatively in Model 2,which included a total of 439 participants with complete
data, the following variables were positively and independ-
ently associated with groin injecting: higher than secondary
level education (adjusted odds ratio [AOR] = 1.62; 95%CI:
1.05 – 2.53), ever injected midazolam (AOR= 4.12; 95%CI:
2.06 – 9.16), binge drug use (AOR= 1.72; 95%CI: 1.11 –
2.69), and drug planting by police (AOR = 1.89; 95%CI:
1.25 – 2.88).
Discussion
In the present study, we found that just over one-third of
a community-recruited sample of PWID in Bangkok re-
ported groin injecting in the past six months. Having
injected in the groin was positively associated with higher
than secondary level education and frequent midazolam
injection. In addition, those who reported drug planting
by police were also more likely to report groin injecting.
The high prevalence of groin injecting observed in
our study builds on a growing body of literature demon-
strating the common use of the groin as a site of injection
among PWID [17,22,23]. Studies conducted in Seattle,
Washington and six locations in the United Kingdom (UK)
(i.e., Manchester, Bristol, Teeside, Plymouth, Exeter, and
Wigan) reported that 40% and 45% of PWID in their sam-
ple had injected in the femoral vein, respectively [4,24]. Sev-
eral reasons for the increasing prevalence of groin injecting
among PWID have been proposed, and these relate to the
wide array of physical health problems, including injection-
related infections and abscesses resulting from frequent in-
jection in peripheral veins (i.e., cubital fossa) [1].
Findings from our first and second model revealed that
midazolam injection in the past six months and a history
of midazolam injection was strongly associated with groin
injecting, respectively. This supports our hypothesis that
previous midazolam injection may predict future groin
injecting among this population, given that this drug in its
soluble form is highly acidic and can be damaging to veins.
Our findings are consistent with previous studies that have
documented that many PWID who inject midazolam have
resorted to groin injection once more convenient sites be-
come inaccessible [7]. Given the known adverse health
outcomes associated with groin injecting [14,25], public
health interventions should first focus on educating PWID
on the risks and harms associated with this practice in
addition to improving the distribution of appropriate
injecting paraphernalia, including sterile needles and sy-
ringes, as well as alcohol swabs [8]. Furthermore, a recent
study conducted in the UK by Zador and colleagues
(2008) revealed that groin injectors were able to success-
fully access and use alternative peripheral injecting sites
following complications due to chronic groin injecting. In
an effort to encourage those engaging in high-risk femoral
injecting behaviour to utilize lower-risk peripheral sites, it
may be of benefit for healthcare workers to support PWID
Table 1 Bivariate analyses of factors associated with groin injection among PWID in Bangkok, Thailand (n = 437)
Groin injection in the last six months n (%)
Characteristic Yes 150 (34.3%) No 287 (65.7%) Odds ratio (95% CI) p
Median age
≥ 38 years 80 (53.3) 151 (52.6) 1.03 (0.69 – 1.53) 0.89
< 38 years 70 (46.7) 136 (47.4)
Gender
Male 119 (79.3) 232 (80.8) 0.91 (0.56 – 1.49) 0.71
Female 31 (20.7) 55 (19.2)
Education level
≥ Secondary education 105 (70.0) 161 (56.1) 1.83 (1.20 – 2.78) <0.01
< Secondary education 45 (30.0) 126 (43.9)
Heroin injection*
> Weekly 41 (27.3) 54 (18.8) 1.83 (1.09 – 3.08) 0.02
≤ Weekly 58 (38.7) 110 (38.3) 1.27 (0.81 – 2.01) 0.30
nNone 51 (34.0) 123 (42.9) 1.00 (reference)
Midazolam injection*
> Weekly 127 (84.7) 113 (39.4) 10.93 (5.59 – 21.37) <0.01
≤ Weekly 12 (8.0) 67 (23.3) 1.74 (0.73 – 4.17) 0.02
None 11 (7.3) 107 (37.3) 1.00 (reference)
Methamphetamine injection*
> Weekly 29 (19.3) 59 (20.6) 0.79 (0.47 – 1.33) 0.38
≤ Weekly 30 (20.0) 81 (28.2) 0.60 (0.37 – 0.98) 0.04
None 91 (60.7) 147 (51.2) 1.00 (reference)
Length of injecting career
Median value (years) 19 18 1.02 (1.00 – 1.04) 0.08
IQR (years) 15 – 27 14 – 24
Binge drug use*
Yes 59 (39.3) 73 (25.4) 1.90 (1.25 – 2.90) <0.01
No 91 (60.7) 214 (74.6)
Syringe sharing*
Yes 33 (22.0) 43 (15.0) 1.60 (0.97 – 2.65) 0.07
No 117 (78.0) 244 (85.0)
Inject in public places*
Yes 45 (30.0) 74 (25.8) 1.23 (0.80 – 1.91) 0.35
No 105 (70.0) 213 (74.2)
Non-fatal overdose*
Yes 6 (4.0) 10 (3.5) 1.15 (0.41 – 3.24) 0.79
No 144 (96.0) 277 (96.5)
Need help injecting*
Yes 25 (16.7) 57 (19.9) 0.81 (0.48 – 1.35) 0.42
No 125 (83.3) 230 (80.1)
Injected with others*
> 75% of the time 57 (38.0) 113 (39.4) 0.94 (0.63 – 1.42) 0.78
≤ 75% of the time 93 (62.0) 174 (60.6)
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Table 1 Bivariate analyses of factors associated with groin injection among PWID in Bangkok, Thailand (n = 437)
(Continued)
Barriers to accessing health services
Any 118 (78.7) 204 (71.1) 1.50 (0.94 – 2.39) 0.09
None 32 (21.3) 83 (28.9)
Drug planting by police
Yes 84 (56.0) 107 (37.3) 2.14 (1.43 – 3.20) <0.01
No 66 (44.0) 180 (62.7)
PWID: people who inject drugs, CI: confidence interval; IQR: interquartile range.
*Activities in the previous six months.
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sites are believed to be no longer accessible [23]. For those
PWID where peripheral vein access is not possible, other
harm reduction interventions such as education on safer
groin injection techniques and the provision of appropri-
ate injection equipment, such as filters and appropriate
needles, may be of value in this setting [5]. Given the high
degree of stigma and discrimination associated with illicit
drug use in Thailand [26,27], educational efforts and ma-
terials might be best provided through existing drug user-
run drop-in centres operating in Bangkok [28].
Although we expected that PWID with higher education
would avoid risky injection practices (i.e., groin injecting),
we found a positive association between higher than sec-
ondary level education and a history of groin injecting in
our study. One possible explanation for this finding may
be that these individuals may be more likely to try to hide
their injecting behaviour from family, friends, healthcare
workers, or law enforcement officials for fear of further
discrimination.
Of concern, PWID who reported having drugs planted





(≥ Secondary education vs. < Secondary education) 1.55 (0
Midazolam injection*
(> Weekly vs. None) 9.67 (5
(≤ Weekly vs. None) 1.56 (0
Ever injected midazolam
(Yes vs. No) -
Binge drug use*
(Yes vs. No) 1.43 (0
Drug planting by police
(Yes vs. No) 2.09 (1
PWID: people who inject drugs; AOR: adjusted odds ratio; CI: confidence interval.
*Activities in the previous six months.injecting. While in other settings this finding would likely
reflect the fact that groin injecting allows PWID to hide
visible track marks from law enforcement [6], previous re-
search conducted in Thailand suggest that increasing rates
of midazolam injection may be playing a role in driving
the aforementioned association. Fairbairn et al. (2009) also
found that a history of midazolam use was associated with
evidence planting by police among Thai PWID. It was
proposed that this may be attributed in part to the drowsy
appearance of PWID when under the influence of midazo-
lam, making these individuals more vulnerable and identi-
fiable to police [18]. As well, midazolam injectors tend to
be of older age and thus, may already have a history with
police [7]. However, our subanalysis focused on identifying
interaction effects between drug planting by police and
midazolam injection failed to yield a statistically significant
result. Given the limited and inconsistent available evi-
dence examining the relationship between policing prac-
tices, midazolam use, and reporting groin injection in this
setting, future research using in-depth qualitative methods
should seek to explore this further. Nevertheless, given the
ineffectiveness of drug law enforcement approaches insociated with groin injection among PWID in
del 1 (n = 437) Model 2 (n = 439)
% CI p-value AOR 95% CI p-value
.97 – 2.50) 0.07 1.62 (1.05 – 2.53) 0.03
.10 – 20.06) <0.01 - - -
.64 – 3.82) 0.33
- - 4.12 (2.06 – 9.16) <0.01
.88 – 2.30) 0.15 1.72 (1.11 – 2.69) 0.02
.33 – 3.29) <0.01 1.89 (1.25 – 2.88) <0.01
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for alternative policy approaches to be developed, imple-
mented and evaluated. In the meantime, efforts should be
made to ensure that policing practices do not undermine
existing public health efforts, including those focused on
promoting safer injecting practices [31]. Additionally,
given the lack of legal grounding for harm reduction ser-
vices in Thailand, efforts to plan and implement a national
harm reduction policy is urgently needed.
This study is limited in several ways. The study sample
was not randomly selected and therefore, it may not be
possible to generalize the findings of this study to Thai
PWID more broadly. Additionally, given that our eligibility
criteria only included individuals who had injected drugs
in the past 6 months, we were unable to explore the risk
factors associated with groin injection among individuals
with a history of injection drug use but who had not
injected drugs in the past six months. The data obtained
are also based on self-reports by PWID and may be sus-
ceptible to socially desirable reporting or recall bias. We
should also note that our findings were limited by the
cross-sectional design of the study, and therefore, we can-
not determine a temporal relationship between exposure
and outcome. Finally, given the nature of the study, there
may be issues related to unmeasured confounding (e.g.,
homelessness, problems accessing peripheral veins, mental
health issues, abuse) that we were not able to capture in
this analysis.
Conclusions
In sum, we found a high prevalence of groin injecting
among Thai PWID, with those who have completed
higher education, those who reported frequent midazolam
injecting, and those who reported drug planting by police
were more likely to engage in groin injecting. Given the
various adverse effects of groin injecting among PWID,
these findings highlight the need for evidence-based public
health interventions that focus on educating PWID on the
harms associated with injecting into the groin. As well, in-
terventions that aim to harmonize public health and po-
licing practices are urgently needed to minimize unsafe
injecting practices.
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